R-Propylisopropyl acetamide
Latest Information Update: 23 Apr 2002
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action GABA uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Epilepsy
Most Recent Events
- 03 May 2000 Preclinical development for Epilepsy in Israel (Unknown route)